Black Rock Inc. Cytosorbents Corp Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Cytosorbents Corp stock. As of the latest transaction made, Black Rock Inc. holds 655,805 shares of CTSO stock, worth $695,153. This represents 0.0% of its overall portfolio holdings.
Number of Shares
655,805
Previous 722,435
9.22%
Holding current value
$695,153
Previous $686,000
33.09%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding CTSO
# of Institutions
58Shares Held
15.7MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.28 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$2.95 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$2.07 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.78 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.32 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $46.2M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...